miR-339-5p levels were significantly reduced in brain specimens isolated from AD patients compared to age-matched controls. Therefore, miR-339-5p regulates BACE1 expression in human brain cells and is most likely dysregulated in at least a subset of AD patients, making this miRNA a novel drug target. This evidence concerns the gene BACE1 and Alzheimer disease.